ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 128 filers reported holding ATEA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $120,966 | -13.3% | 40,322 | +8.0% | 0.00% | – |
| Q2 2023 | $139,573 | -27.2% | 37,319 | -34.8% | 0.00% | – |
| Q1 2023 | $191,641 | +26.5% | 57,206 | +81.7% | 0.00% | – |
| Q4 2022 | $151,438 | -14.0% | 31,484 | +1.6% | 0.00% | – |
| Q3 2022 | $176,000 | -90.7% | 30,974 | -88.4% | 0.00% | -100.0% |
| Q2 2022 | $1,892,000 | +6.2% | 266,578 | +8.0% | 0.00% | 0.0% |
| Q1 2022 | $1,782,000 | +172.5% | 246,794 | +237.1% | 0.00% | – |
| Q4 2021 | $654,000 | -80.1% | 73,215 | -22.0% | 0.00% | -100.0% |
| Q3 2021 | $3,293,000 | +295.3% | 93,907 | +142.3% | 0.00% | – |
| Q2 2021 | $833,000 | +38.8% | 38,757 | +299.2% | 0.00% | – |
| Q1 2021 | $600,000 | +35.4% | 9,709 | -8.4% | 0.00% | – |
| Q4 2020 | $443,000 | – | 10,594 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tyrus Capital S.A.M. | 1,260,000 | $3,780,000 | 35.90% |
| BML Capital Management, LLC | 4,800,000 | $14,400,000 | 13.22% |
| Stonepine Capital Management, LLC | 1,720,000 | $5,160,000 | 1.71% |
| TANG CAPITAL MANAGEMENT LLC | 3,600,000 | $10,800,000 | 1.52% |
| CM Management, LLC | 275,000 | $825,000 | 0.88% |
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $7,456,914 | 0.83% |
| EcoR1 Capital, LLC | 6,995,861 | $20,987,583 | 0.71% |
| SECTORAL ASSET MANAGEMENT INC | 600,461 | $1,801,383 | 0.35% |
| Newtyn Management, LLC | 400,000 | $1,200,000 | 0.30% |
| Diametric Capital, LP | 200,000 | $600,000 | 0.25% |